Novo Nordisk A/S Price Today

image quote

Novo Nordisk A/S

NVO

Healthcare

$568.72B

๐Ÿ’ฐ

Market Cap

47.2

๐Ÿ’ธ

Price to Earnings

$2.7

๐ŸŽ‰

EPS

+0

๐ŸŒณ

ESG
Consensus Recommendations

Buy Consensus

Buy
14
Strong Buy
6
Hold
10
Sell
0
Strong Sell
1

NVO Price Forecast Target

127.5 ๐Ÿ‘‰ 160.0 +26%

NVO EPS Forecast

2.7 ๐Ÿ‘‰ 4.0 +47%
Financials

Profit Margin

36 %

Revenue Growth

37.0 %

Dividend

$ 1.37
Held Percent
0.0% - Insiders 9.3% - Institutions 90.7% - Public
Major Fund Holders
  • ๐Ÿ’ฐ $
  • ๐Ÿ’ฐ $
  • ๐Ÿ’ฐ $
  • ๐Ÿ’ฐ $
  • ๐Ÿ’ฐ $
Stock Ideas
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to esโ€ฆ
Scott Ferguson Portfolio
With a strong background as a protรฉgรฉ of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with โ€ฆ
Christopher Hohn Portfolio
Christopher Hohn is a British hedge fund manager and philanthropist. He founded The Children's Investment Fund Management in 2003, one of Europe's largest hedge funds. Known for his activist investment approach, Hohn targets undervalued companies wiโ€ฆ
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples aโ€ฆ

๐Ÿ“ฎFAQ

Some Frequently Asked Questions.

rocket money aiovel
The Novo Nordisk A/S industry is Biotechnology

rocket money aiovel
The Novo Nordisk A/S sector is Healthcare

rocket money aiovel
The Novo Nordisk A/S forecasted predicted Price to Earnings PE ratio is 32.1

rocket money aiovel
The Novo Nordisk A/S Price to Earnings PE ratio is 47.2

rocket money aiovel
The Market Capitalization of Novo Nordisk A/S is $568.72B

rocket money aiovel
There are total of 3192981244 float shares with 9.3% held by Institutions and 0.0% held by insiders

rocket money aiovel
The MNovo Nordisk A/S forecasted Earnings per Share EPS is $4.0

rocket money aiovel
The Novo Nordisk A/S Earnings per Share EPS is 2.7

rocket money aiovel
The Novo Nordisk A/S company has $0 gross profits with 36 profit margins

rocket money aiovel
The Novo Nordisk A/S Earnings Growth is 0.631% with 0.616% quarterly earnings growth

rocket money aiovel
The Novo Nordisk A/S Revenue is $232260993024 with 0.37 revenue growth

rocket money aiovel
The price target for Novo Nordisk A/S stock is $160.0 for the high target and $130.0 for the low target

rocket money aiovel
The consensus analyst recommendations for Novo Nordisk A/S is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.

rocket money aiovel
The consensus analyst recommendations for Novo Nordisk A/S is Buy, with the following breakdown:
  • Buy: 14
  • Strong Buy: 6
  • Hold: 10
  • Sell: 0
  • Strong Sell: 1

rocket money aiovel
The Beta of Novo Nordisk A/S is 0.2

rocket money aiovel
The dividend of Novo Nordisk A/S is $1.37

rocket money aiovel
The dividend yield of Novo Nordisk A/S is 0.0108%

rocket money aiovel
The biggest institutional and mutual fund holders of Novo Nordisk A/S stock are

rocket money aiovel
The Novo Nordisk A/S ESG Score is 0, with the following breakdown:
  • E: 0
  • S: 0
  • G: 0
NVO Stock
Novo Nordisk A/S Stock Symbol
NVO Share
NVO Stock Price
NVO Shares Price
NVO Stock Market Predictions
NVO Stock Targets
NVO Stock Analysis
NVO Stock Screener
NVO Stock Forecast
NVO Stock Price
NVO Stock Graph
NVO Stock Chart
NVO Stock Dividend
Novo Nordisk A/S Earnings
Novo Nordisk A/S buy sell or hold
Novo Nordisk A/S Net Worth
NVO pre market price
NVO market value
NVO ESG rating